Owens & Minor (NYSE:OMI – Get Free Report) is scheduled to be posting its quarterly earnings results before the market opens on Friday, May 3rd. Analysts expect Owens & Minor to post earnings of $0.17 per share for the quarter. Owens & Minor has set its FY 2024 guidance at 1.400-1.700 EPS and its FY24 guidance at $1.40-$1.70 EPS.Individual that wish to listen to the company’s earnings conference call can do so using this link.
Owens & Minor (NYSE:OMI – Get Free Report) last posted its quarterly earnings data on Tuesday, February 20th. The company reported $0.69 earnings per share for the quarter, topping the consensus estimate of $0.66 by $0.03. The business had revenue of $2.66 billion during the quarter, compared to analysts’ expectations of $2.67 billion. Owens & Minor had a negative net margin of 0.40% and a positive return on equity of 11.62%. Owens & Minor’s revenue was up 4.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.28 earnings per share. On average, analysts expect Owens & Minor to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Owens & Minor Stock Down 2.5 %
OMI stock opened at $24.12 on Friday. The stock has a market capitalization of $1.85 billion, a P/E ratio of -44.67, a price-to-earnings-growth ratio of 0.81 and a beta of 0.43. The company has a current ratio of 1.11, a quick ratio of 0.52 and a debt-to-equity ratio of 2.05. Owens & Minor has a 12 month low of $13.34 and a 12 month high of $28.35. The firm has a 50-day moving average price of $25.16 and a 200-day moving average price of $21.05.
Insider Transactions at Owens & Minor
Analyst Ratings Changes
A number of research analysts recently issued reports on OMI shares. TheStreet upgraded shares of Owens & Minor from a “d+” rating to a “c-” rating in a report on Monday, March 4th. Robert W. Baird increased their target price on shares of Owens & Minor from $24.00 to $28.00 and gave the company a “neutral” rating in a research report on Wednesday, April 10th. StockNews.com raised shares of Owens & Minor from a “hold” rating to a “buy” rating in a research report on Wednesday, February 21st. UBS Group decreased their target price on shares of Owens & Minor from $28.00 to $26.00 and set a “buy” rating for the company in a research report on Monday, January 29th. Finally, SVB Leerink assumed coverage on shares of Owens & Minor in a research report on Monday, February 26th. They set a “market perform” rating and a $24.00 target price for the company. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $23.29.
Read Our Latest Analysis on OMI
Owens & Minor Company Profile
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.
Further Reading
- Five stocks we like better than Owens & Minor
- Upcoming IPO Stock Lockup Period, Explained
- Hasbro’s Management Made All the Right Calls This Quarter
- What is the NASDAQ Stock Exchange?
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- What is the S&P/TSX Index?
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.